Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy LumiraDx Limited stock

Learn how to easily invest in LumiraDx Limited stock.

LumiraDx Limited is a diagnostics & research business based in the US. LumiraDx Limited shares (LMDX) are listed on the NASDAQ and all prices are listed in US Dollars. LumiraDx Limited employs 1,513 staff and has a trailing 12-month revenue of around $331.6 million.

How to buy LumiraDx Limited stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – LMDX. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

LumiraDx Limited stock price (NASDAQ: LMDX)

Use our graph to track the performance of LMDX stocks over time.

LumiraDx Limited shares at a glance

Information last updated 2023-01-27.
Latest market close$0.98
52-week range$0.77 - $9.43
50-day moving average $1.05
200-day moving average $2.04
Wall St. target price$3.49
PE ratio 8.8
Dividend yield $0 (0%)
Earnings per share (TTM) $0.10

Buy LumiraDx Limited stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy LumiraDx Limited stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LumiraDx Limited price performance over time

Historical closes compared with the close of $0.9799 from 2023-02-01

1 week (2023-01-26) 11.35%
1 month (2023-01-03) 10.10%
3 months (2022-11-03) -5.78%
6 months (2022-08-03) -40.61%
1 year (2022-02-03) -88.98%
2 years (2021-01-30) N/A
3 years (2020-01-30) N/A
5 years (2018-01-30) N/A

Is LumiraDx Limited stock undervalued or overvalued?

Valuing LumiraDx Limited stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LumiraDx Limited's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LumiraDx Limited's P/E ratio

LumiraDx Limited's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, LumiraDx Limited shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, LumiraDx Limited's P/E ratio is best considered in relation to those of others within the diagnostics & research industry or those of similar companies.

LumiraDx Limited financials

Revenue TTM $331.6 million
Gross profit TTM $151.5 million
Return on assets TTM -18.22%
Return on equity TTM -378.14%
Profit margin -115.87%
Book value $0.06
Market capitalisation $279.6 million

TTM: trailing 12 months

LumiraDx Limited share dividends

We're not expecting LumiraDx Limited to pay a dividend over the next 12 months.

LumiraDx Limited overview

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of LumiraDx Limited is owned by insiders or institutions?
Currently 77.614% of LumiraDx Limited shares are held by insiders and 26.684% by institutions.
How many people work for LumiraDx Limited?
Latest data suggests 1,513 work at LumiraDx Limited.
When does the fiscal year end for LumiraDx Limited?
LumiraDx Limited's fiscal year ends in December.
Where is LumiraDx Limited based?
LumiraDx Limited's address is: 3 More London Riverside, London, United Kingdom, SE1 2AQ
What is LumiraDx Limited's ISIN number?
LumiraDx Limited's international securities identification number is: KYG5709L1095

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site